These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33138297)

  • 1. Salinosporamide A, a Marine-Derived Proteasome Inhibitor, Inhibits T Cell Activation through Regulating Proliferation and the Cell Cycle.
    Lee HS; Jeong GS
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33138297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antileukemic activity and mechanism of drug resistance to the marine Salinispora tropica proteasome inhibitor salinosporamide A (Marizomib).
    Niewerth D; Jansen G; Riethoff LF; van Meerloo J; Kale AJ; Moore BS; Assaraf YG; Anderl JL; Zweegman S; Kaspers GJ; Cloos J
    Mol Pharmacol; 2014 Jul; 86(1):12-9. PubMed ID: 24737138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salinosporamide A (NPI-0052) potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through down-modulation of NF-kappaB regulated gene products.
    Ahn KS; Sethi G; Chao TH; Neuteboom ST; Chaturvedi MM; Palladino MA; Younes A; Aggarwal BB
    Blood; 2007 Oct; 110(7):2286-95. PubMed ID: 17609425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthetic convergence of salinosporamides A and B in the marine actinomycete Salinispora tropica.
    Beer LL; Moore BS
    Org Lett; 2007 Mar; 9(5):845-8. PubMed ID: 17274624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of salinosporamide A and its analogs as 20S proteasome inhibitors and SAR summarization.
    Ma Y; Qu L; Liu Z; Zhang L; Yang Z; Zhang L
    Curr Top Med Chem; 2011 Dec; 11(23):2906-22. PubMed ID: 21824108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial self-resistance to the natural proteasome inhibitor salinosporamide A.
    Kale AJ; McGlinchey RP; Lechner A; Moore BS
    ACS Chem Biol; 2011 Nov; 6(11):1257-64. PubMed ID: 21882868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered biosynthesis of antiprotealide and other unnatural salinosporamide proteasome inhibitors.
    McGlinchey RP; Nett M; Eustáquio AS; Asolkar RN; Fenical W; Moore BS
    J Am Chem Soc; 2008 Jun; 130(25):7822-3. PubMed ID: 18512922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A concise and straightforward total synthesis of (+/-)-salinosporamide A, based on a biosynthesis model.
    Mulholland NP; Pattenden G; Walters IA
    Org Biomol Chem; 2008 Aug; 6(15):2782-9. PubMed ID: 18633536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salinosporamide natural products: Potent 20 S proteasome inhibitors as promising cancer chemotherapeutics.
    Gulder TA; Moore BS
    Angew Chem Int Ed Engl; 2010 Dec; 49(49):9346-67. PubMed ID: 20927786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marizomib, a potent second generation proteasome inhibitor from natural origin.
    Ma L; Diao A
    Anticancer Agents Med Chem; 2015; 15(3):298-306. PubMed ID: 25403165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective overproduction of the proteasome inhibitor salinosporamide A via precursor pathway regulation.
    Lechner A; Eustáquio AS; Gulder TA; Hafner M; Moore BS
    Chem Biol; 2011 Dec; 18(12):1527-36. PubMed ID: 22195555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of biochemical and biological effects of ML858 (salinosporamide A) and bortezomib.
    Williamson MJ; Blank JL; Bruzzese FJ; Cao Y; Daniels JS; Dick LR; Labutti J; Mazzola AM; Patil AD; Reimer CL; Solomon MS; Stirling M; Tian Y; Tsu CA; Weatherhead GS; Zhang JX; Rolfe M
    Mol Cancer Ther; 2006 Dec; 5(12):3052-61. PubMed ID: 17172407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salinosporamides D-J from the marine actinomycete Salinispora tropica, bromosalinosporamide, and thioester derivatives are potent inhibitors of the 20S proteasome.
    Reed KA; Manam RR; Mitchell SS; Xu J; Teisan S; Chao TH; Deyanat-Yazdi G; Neuteboom ST; Lam KS; Potts BC
    J Nat Prod; 2007 Feb; 70(2):269-76. PubMed ID: 17243724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship studies of salinosporamide A (NPI-0052), a novel marine derived proteasome inhibitor.
    Macherla VR; Mitchell SS; Manam RR; Reed KA; Chao TH; Nicholson B; Deyanat-Yazdi G; Mai B; Jensen PR; Fenical WF; Neuteboom ST; Lam KS; Palladino MA; Potts BC
    J Med Chem; 2005 Jun; 48(11):3684-7. PubMed ID: 15916417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus salinospora.
    Feling RH; Buchanan GO; Mincer TJ; Kauffman CA; Jensen PR; Fenical W
    Angew Chem Int Ed Engl; 2003 Jan; 42(3):355-7. PubMed ID: 12548698
    [No Abstract]   [Full Text] [Related]  

  • 16. Marine actinomycetes: a new source of compounds against the human malaria parasite.
    Prudhomme J; McDaniel E; Ponts N; Bertani S; Fenical W; Jensen P; Le Roch K
    PLoS One; 2008 Jun; 3(6):e2335. PubMed ID: 18523554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New cytotoxic salinosporamides from the marine Actinomycete Salinispora tropica.
    Williams PG; Buchanan GO; Feling RH; Kauffman CA; Jensen PR; Fenical W
    J Org Chem; 2005 Aug; 70(16):6196-203. PubMed ID: 16050677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marizomib (Salinosporamide A) Promotes Apoptosis in A375 and G361 Melanoma Cancer Cells.
    Piskorz WM; Krętowski R; Cechowska-Pasko M
    Mar Drugs; 2024 Jul; 22(7):. PubMed ID: 39057424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generating a generation of proteasome inhibitors: from microbial fermentation to total synthesis of salinosporamide a (marizomib) and other salinosporamides.
    Potts BC; Lam KS
    Mar Drugs; 2010 Mar; 8(4):835-80. PubMed ID: 20479958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon monoxide inhibits T lymphocyte proliferation via caspase-dependent pathway.
    Song R; Mahidhara RS; Zhou Z; Hoffman RA; Seol DW; Flavell RA; Billiar TR; Otterbein LE; Choi AM
    J Immunol; 2004 Jan; 172(2):1220-6. PubMed ID: 14707100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.